We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Benchtop Analyzer Designed for Routine Clinical Chemistry Testing

By LabMedica International staff writers
Posted on 03 Aug 2011
Print article
Image: Indiko Benchtop chemistry analyzer (Photo courtesy of Thermo Scientific).
Image: Indiko Benchtop chemistry analyzer (Photo courtesy of Thermo Scientific).
A fully automated, compact, random access chemistry analyzer for use in small laboratory settings is an easy to use, cost-effective system

Dubbed Indiko, the analyzer is designed for routine clinical chemistry testing and specialty testing such as specific proteins, drug of abuse testing, and therapeutic drug monitoring including immunosuppressant drug monitoring (ISD).

A mix of barcoded primary tubes and sample cups can be used at any time, increasing the flexibility of operation. Patient oriented testing produces results quickly thus enhancing the quality of patient care.

Features of Indiko include advanced dilution management and real-time monitoring of reagent usage, which help to manage a daily workload. Samples, reagents, and consumables can continuously be loaded without interrupting the testing process, and different sample types can be analyzed at the same time. A real-time QC program with multiple Westgard Rules assures the reliable performance. Application data as well as calibrator and control values are loadable from a file or from a two-dimensional barcode by the barcode scanner.

The test flow definition allows for up to four reagent additions in each test, offering automation even for the most complex methods. The cuvette design supports low reagent volumes thus reducing operating costs, especially important when working with specialty tests.

Thermo Fisher Scientific (Waltham, MA, USA) introduced Indiko during the American Association for Clinical Chemistry (AACC) 2011 conference, which was held from July 26-28, 2011, at the Georgia World Congress Center, Atlanta (GA, USA). The analyzer has received US Food and Drug Administration (FDA; Silver Spring, MD, USA) clearance.

Additional information about the Indiko analyzer may be found online (please see Related Links below).


Related Links:
Thermo Fisher Scientific
Thermo Scientific Indiko
US Food and Drug Administration


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit
New
Coagulation Analyzer
CS-2400

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.